We are live on
!
Find out more
BM
Brandywine Managers Portfolio holdings
AUM
$202M
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter
Est. Return
+30.85%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$202M
AUM Growth
+$32.2M
(+19%)
Cap. Flow
+$977K
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
85.78%
Holding
46
New
6
Increased
3
Reduced
6
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.06M |
| 2 |
Celcuity
CELC
|
+$764K |
| 3 |
Astera Labs
ALAB
|
+$429K |
| 4 |
SNDK
Sandisk
SNDK
|
+$357K |
| 5 |
Immuneering
IMRX
|
+$279K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$773K |
| 2 |
NVIDIA
NVDA
|
+$757K |
| 3 |
Eli Lilly
LLY
|
+$347K |
| 4 |
Intuitive Surgical
ISRG
|
+$284K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$256K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 36.68% |
| 2 | Technology | 31.31% |
| 3 | Miscellaneous | 22.8% |
| 4 | Healthcare | 8.43% |
| 5 | Financials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
10x Genomics
TXG
$8.1B
| $726K | 0.36% |
18,938
| – | – |
|
27
Relay Therapeutics
RLAY
$4.16B
| $719K | 0.36% |
38,429
| – | – |
|
28
Structure Therapeutics
GPCR
$3.36B
| $717K | 0.35% |
13,357
| – | – |
|
|
29
Alnylam Pharmaceuticals
ALNY
$35.3B
| $698K | 0.35% |
2,318
-850
| -27% | -$256K |
|
|
30
Celcuity
CELC
$4.67B
| $693K | 0.34% |
+6,621
| New | +$764K |
|
|
BLLN
31
BillionToOne Inc
BLLN
$4.73B
| $690K | 0.34% |
5,750
| – | – |
|
32
Moderna
MRNA
$58.4B
| $666K | 0.33% |
9,510
| – | – |
|
33
Alphabet (Google) Class C
GOOG
$4.1T
| $656K | 0.32% |
1,857
| – | – |
|
|
SNDK
34
Sandisk
SNDK
$252B
| $568K | 0.28% |
+250
| New | +$357K |
|
35
Twilio
TWLO
$36B
| $486K | 0.24% |
2,357
| – | – |
|
|
36
Intuitive Surgical
ISRG
$129B
| $480K | 0.24% |
1,208
-650
| -35% | -$284K |
|
37
Viking Therapeutics
VKTX
$4.02B
| $480K | 0.24% |
12,301
| – | – |
|
38
Schrodinger
SDGR
$1.48B
| $462K | 0.23% |
28,456
| – | – |
|
|
39
Eli Lilly
LLY
$1.02T
| $428K | 0.21% |
357
-340
| -49% | -$347K |
|
40
Okta
OKTA
$30.1B
| $383K | 0.19% |
2,809
| – | – |
|
41
PagerDuty
PD
$1.08B
| $294K | 0.15% |
30,517
| – | – |
|
|
HTFL
42
Heartflow Inc
HTFL
$4.28B
| $294K | 0.15% |
10,024
-6,750
| -40% | -$203K |
|
|
43
Immuneering
IMRX
$315M
| $275K | 0.14% |
+55,066
| New | +$279K |
|
44
Klaviyo
KVYO
$5.33B
| $262K | 0.13% |
17,384
| – | – |
|
45
Immatics
IMTX
$1.43B
| $256K | 0.13% |
+25,227
| New | +$267K |
|
46
AbCellera Biologics
ABCL
$3.69B
| $224K | 0.11% |
28,488
| – | – |
|
Similar funds
OPL
WPW
HWA
DFG
LAMC
FC
ER
MRCM
Brandywine Managers's Q2 2026 Portfolio in Review
As of Q2 2026, Brandywine Managers held 46 positions worth $202M, up 19% from $170M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Brandywine Managers's Q2 2026 filing shows 6 new, 3 increased and 6 reduced positions. Its largest new stake was Micron Technology: 1,416 shares worth $1.63M. The largest sale was Advanced Micro Devices, an estimated $773K.
By sector, the portfolio is most concentrated in Consumer Staples at 37% of assets, down from 44% a quarter earlier, followed by Technology and Miscellaneous.
- Brandywine Managers's largest Q2 2026 buy was Micron Technology: 1,416 shares worth $1.63M.
- Brandywine Managers added most to CrowdStrike in Q2 2026, an estimated $179K increase.
- Brandywine Managers's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $773K.
- Brandywine Managers's ten largest holdings make up 86% of its $202M portfolio in Q2 2026.
- Brandywine Managers opened 6 new positions and closed 0 in Q2 2026.
- Brandywine Managers's portfolio value rose 19% quarter-over-quarter to $202M.
Based on Brandywine Managers's 13F filing for Q2 2026, filed 14 Aug 2026.